White matter hyperintensities in bipolar disorder: systematic review and meta-analysis

Tânia Silva1,2,3, Cesar Nunes4, Andreia Ribeiro1,3

  • 1Department of Psychiatry, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Frontiers in Psychiatry
|February 12, 2024
PubMed
Abstract

Insights

Bipolar disorder patients show a significantly higher prevalence of white matter hyperintensities (WMH) compared to healthy individuals. This meta-analysis highlights a greater WMH burden in those with bipolar disorder.

Area of Science:

  • Neuroimaging and Psychiatry
  • Cerebral Small Vessel Disease Research
  • Cognitive Impairment Studies

Background:

  • White matter hyperintensities (WMH) are linked to cerebral small vessel disease and cognitive decline.
  • WMH prevalence in bipolar disorder (BD) is debated, necessitating further investigation.
  • Understanding WMH in BD is crucial for cognitive impairment and dementia risk assessment.

Approach:

  • A systematic literature search was conducted across Embase, Medline/PubMed, and reference lists.
  • Meta-analysis of 22 case-control studies involving 1313 participants was performed.
  • Prevalence of WMH in adults with BD was compared against healthy controls using T2-weighted MRI.

Key Points:

  • The pooled prevalence of WMH was 46.5% in BD patients versus 28% in controls.
  • A pooled Odds Ratio of 2.89 (95% CI 1.76; 4.75) indicates a higher likelihood of WMH in BD.
  • Moderate heterogeneity (I² = 0.49) was observed across the included studies.

Conclusions:

  • Adults with bipolar disorder exhibit a significantly higher burden of white matter hyperintensities.
  • Limitations include inability to analyze gender/bipolar type differences and moderate study heterogeneity.
  • Further research controlling for confounders and exploring demographic variations is warranted.

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
244
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
643
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
57